Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$22,635,644
+$5,561,954 QoQ
Shares Held
18,872
+1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.28%
of 13F equity value
Holder Rank
#837
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACKSON SQUARE CAPITAL, LLC holds $34,281,243 across 7 Drug Manufacturers - General names. LLY ranks #1 (66.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
18,872 | $22,635,644 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,686 | $4,457,151 | |
| 3 | ABBV |
AbbVie Inc.
|
14,566 | $3,665,388 | |
| 4 | JNJ |
Johnson & Johnson
|
7,767 | $1,972,584 | |
| 5 | NVS |
Novartis AG
|
3,643 | $570,930 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,490 | $546,813 | |
| 7 | AMGN |
Amgen Inc
|
1,195 | $432,733 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,635,644 | 18,872 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $17,073,690 | 18,563 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $19,813,877 | 18,437 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $11,110,806 | 14,562 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $15,833,033 | 20,311 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $15,826,087 | 19,162 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $14,822,400 | 19,200 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $20,267,649 | 22,877 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $21,905,669 | 24,195 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $18,735,610 | 24,083 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $14,018,060 | 24,048 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $12,971,152 | 24,149 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $11,097,473 | 23,663 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $8,845,812 | 25,758 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $8,673,700 | 23,709 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $7,884,566 | 24,384 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $8,115,152 | 25,029 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $7,010,623 | 24,481 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $6,261,354 | 22,668 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $5,123,764 | 22,176 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,098,098 | 22,212 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $4,201,208 | 22,488 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $3,064,108 | 18,148 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $3,059,869 | 20,672 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $3,240,913 | 19,740 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $1,596,112 | 11,506 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||